Biogen Inc
BIIB·Stocks·Pharmaceuticals Major·United States·Nasdaq·USD
Price
$232.00
Today
+0.4%
YTD
+32.0%
About
Biogen, Inc. is a biopharmaceutical company founded in 1978. It specialises in designing medications targeting neurological and neurodegenerative disorders. Headquartered in Cambridge, Massachusetts, Biogen operates internationally in the Americas, Europe, Australia, and Asia. The company is listed on the NASDAQ under the ticker BIIB. Broaden your investment scope by buying BIIB stock.
Price chart
Closing price history for BIIB (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.
Open positions
0
Unrealized return
+0.0%
No open positions exist for this instrument at the moment.
Financial insights
Valuation
P/E (TTM)39.60
P/S (TTM)3.44
P/B (TTM)1.75
Market cap$33.04B
Cap tierLarge-cap
Industry avg P/E-7.35
Profitability
Gross margin64.29%
EBIT margin19.50%
Net margin3.72%
ROE4.58%
ROA2.76%
Earnings & Revenue
Revenue (TTM)$9.66B
Revenue growth (1Y)+0.5%
EPS (TTM)$5.65
Free cash flow$2.70B
Total debt$8.36B
Dividends & Risk
Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)0.57
Employees7,500
Next earnings28 Oct '26
Trade history
Closed trades
1
Realized return
+0.5%
| Opened | Closed | P/L% | Open / Target / Close | |
|---|---|---|---|---|
| 17 Nov '20 | 31d | 18 Dec '20 | +0.53% | $250.91→$300.00→$252.25 |